Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cytokinetics
Biotech
Cytokinetics not in sale process, CEO says
Cytokinetics’ CEO Robert Blum has put the kibosh on the rumor that Novartis will acquire the biotech.
Gabrielle Masson
Feb 28, 2024 11:25am
Novartis backs out of Cytokinetics deal: reports
Jan 12, 2024 5:26am
Novartis 'pretty aggressive' in neuroscience BD, R&D chief says
Jan 8, 2024 3:49pm
Cytokinetics' heart failure drug improves exercise capacity
Dec 27, 2023 8:43am
Cytokinetics' pipeline tumble persists after ALS med flops
Mar 31, 2023 11:03am
FDA advisers nix Cytokinetics heart failure med, subgroup data
Dec 13, 2022 8:04pm